U.S. Supreme Court Holds That State-Law-Based Failure-to-Warn Claims Are Federally Preempted Against Generic Drug Manufacturers

more+
less-

On June 23, 2011, the U.S. Supreme Court issued a decision in Pliva, Inc. v. Mensing,1 holding that state-law claims against generic drug manufacturers are federally preempted pursuant to the Supremacy Clause of the U.S. Constitution. The case evaluated the tension between state-law-based duty-to-warn claims of risks inherent in medications and the Hatch-Waxman amendments to the federal Food, Drug, and Cosmetic Act (FDCA), which require generic drug warnings to mirror those of their bioequivalent branded pharmaceutical products. The Court found conflict preemption existed insofar as it was impossible for the defendant generic drug manufacturers to simultaneously comply with federal law and state-law duties.

The Court framed the issue as "whether federal drug regulations applicable to generic drug manufacturers directly conflict with, and thus pre-empt. . . state-law claims." In the underlying lawsuits, the plaintiffs alleged that the defendant generic drug manufacturers failed to provide adequate warning labels and were thus liable under state tort law. Conversely, the defendant generic drug manufacturers contended that federal statutes and U.S. Food and Drug Administration (FDA) regulations required their labels to be the "same as" brand drug manufacturers' labeling.

Please see full alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Administrative Agency Updates, Conflict of Laws Updates, Constitutional Law Updates, Products Liability Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Duane Morris LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

CONNECT

Evolving from a partnership of prominent lawyers in Philadelphia a century ago, Duane Morris now has... View Profile »


Follow Duane Morris LLP:

Reporters on Deadline